Chelsea M McLean (Chelsea McLean)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Vaccines

PloS one

Science translational medicine

Nature communications

Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Netherlands

Postdoctoral Researcher

University of Oxford

United Kingdom

Postdoctoral Researcher :: Radiation Oncology and Biology

Education History

Cornell University

United States

PHD :: Molecular Biology and Genetics

Publications

Edward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo, Daniel Mukadi, Aboubacar Soumah, Zephyrin Mossoko, Tansy Edwards, Darius Tetsa-Tata, Rockyath Makarimi, Oumar Toure, Grace Mambula, Hannah Brindle, Anton Camacho, Nicholas E Connor, Pierre Mukadi, Chelsea M McLean, Babajide Keshinro, Auguste Gaddah, Cynthia Robinson, Kerstin Luhn, Julie Foster, Chrissy H Roberts, John Emery Johnson, Nathalie Imbault, Daniel G Bausch, Rebecca F Grais, Deborah Watson-Jones, Jean Jacques Muyembe-Tamfum, null null
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo. Vaccines 12 (8) (2024)
Ynke Larivière, Irene Garcia-Fogeda, Trésor Matuvanga Zola, Bernard Isekah Osang'ir, Solange Milolo, Rachel Meta, Primo Kimbulu, Cynthia Robinson, Michael Katwere, Chelsea M McLean, Niel Hens, Junior Rika Matangila, Vivi Maketa, Patrick Mitashi, Hypolite Mavoko Muhindo, Jean-Pierre Van Geertruyden, Pierre van Damme
Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo. The Journal of infectious diseases (2023)
Viki Bockstal, Georgi Shukarev, Chelsea M McLean, Neil Goldstein, Stephan Bart, Auguste Gaddah, Dickson Anumenden, Jeroen N Stoop, Anne Marit de Groot, Maria G Pau, Jenny Hendriks, Stephen C De Rosa, Kristen W Cohen, M Juliana McElrath, Benoit Callendret, Kerstin Luhn, Macaya Douoguih, Cynthia Robinson
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study. PloS one 17 (10) (2022)
João M Fernandes Neto, Ernest Nadal, Evert Bosdriesz, Salo N Ooft, Lourdes Farre, Chelsea M McLean, Sjoerd Klarenbeek, Anouk Jurgens, Hannes Hagen, Liqin Wang, Enriqueta Felip, Alex Martinez-Marti, August Vidal, Emile E Voest, Lodewyk F A Wessels, Olaf van Tellingen, Alberto Villanueva, René Bernards
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours. Nature communications 11 (1) (2020)
Salo N Ooft, Fleur Weeber, Krijn K Dijkstra, Chelsea M McLean, Sovann Kaing, Erik D van Werkhoven, Luuk Schipper, Louisa Hoes, Daniel J Vis, Joris van de Haar, Warner Prevoo, Petur Snaebjornsson, Daphne L van der Velden, Michelle Klein, Myriam Chalabi, Henk Boot, Monique E van Leerdam, Haiko J Bloemendal, Laurens V Beerepoot, Lodewyk Wessels, Edwin Cuppen, Hans Clevers, Emile E Voest
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Science translational medicine 11 (513) (2020)

Chelsea M McLean.css-eqlu8i{font-size:small;padding-left:4px;} (Chelsea McLean)

Publication Activity (10 Years)

Top Topics

Top Venues

Chelsea M McLean (Chelsea McLean)